Reuters -- Healthcare products company Covidien said it had signed a definitive agreement to sell its specialty chemical business to an affiliate of New Mountain Capital LLC for $280 million in cash.
Reuters -- Healthcare products company Covidien said it had signed a definitive agreement to sell its specialty chemical business to an affiliate of New Mountain Capital LLC for $280 million in cash.